pfizer dividende 2021 auszahlungstermin

Date Pay. The board of directors of Pfizer Inc. (NYSE:PFE) declared a 39-cent first-quarter 2021 dividend on the company’s common stock, payable March 5, 2021… At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. Chuck Triano */ Current dividend yield. (212) 733-3901 Pfizer's last dividend payment date was on 2021-03-05, when Pfizer shareholders who owned PFE shares before 2021-01-28 received a dividend payment of $0.39 per share. For more than 170 years, we have worked to make a difference for all who rely on us. © 2021, Nasdaq, Inc. All Rights Reserved. Now 1/2 hr ago they expect 15 billion from only 1/2 of the sales this year and the stock went down. Q1 2021 Dividend: 29 April 2021: 20 May 2021: 21 May 2021: 10 June 2021: Q2 2021 Dividend: 22 July 2021: 5 August 2021: 6 August 2021: 8 September 2021: Q3 2021 Dividend: 21 October 2021: 4 November 2021: 5 November 2021: 1 December 2021: Back to top. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results,” as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com. NEW YORK--(BUSINESS WIRE)-- Board of Directors approves quarterly cash dividend of $0.38 per share NEW YORK--(BUSINESS WIRE)-- The board of directors of Pfizer Inc. (NYSE:PFE) declared a 38-cent fourth-quarter 2020 dividend on the company’s common stock, payable December 1, 2020, to holders of the Common Stock of record at the close of business on November 6, 2020. Risks and uncertainties include, among other things, the uncertainties inherent in research and development, including the ability to meet anticipated clinical endpoints, commencement and/or completion dates for our clinical trials, regulatory submission dates, regulatory approval dates and/or launch dates, as well as the possibility of unfavorable new clinical data and further analyses of existing clinical data; the risk that clinical trial data are subject to differing interpretations and assessments by regulatory authorities; whether regulatory authorities will be satisfied with the design of and results from our clinical studies; whether and when any drug applications may be filed for any of our product candidates in any jurisdiction; whether and when regulatory authorities in any jurisdictions where any applications are pending or may be submitted for our product candidates may approve any such applications, which will depend on myriad factors, including making a determination as to whether the product’s benefits outweigh its known risks and determination of the product’s efficacy, and, if approved, whether they will be commercially successful; decisions by regulatory authorities impacting labeling, manufacturing processes, safety and/or other matters that could affect the availability or commercial potential of our product candidates; the uncertainties inherent in business and financial planning, including, without limitation, risks related to Pfizer’s business and prospects, or any of our joint venture or business development counterparties’ business and prospects, adverse developments in Pfizer’s markets, or adverse developments in the U.S. or global capital markets, credit markets, regulatory environment or economies generally; uncertainties regarding the impact of COVID-19 on Pfizer’s business, operations and financial results; and competitive developments. Investors of record on Friday, January 29th will be paid a dividend of 0.39 per share by the biopharmaceutical company on Friday, March 5th. This represents a $1.56 annualized dividend and a yield of 4.18%. (212) 733-3901 Shareholders received 0.124079 shares of Viatris common stock for every one share owned of Pfizer, and Viatris should start paying a dividend in the second quarter of 2021. The first-quarter 2021 cash dividend will be the 329 th consecutive quarterly dividend paid by Pfizer. The first-quarter 2021 cash dividend will be the 329 th consecutive quarterly dividend paid by Pfizer. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. December 14, 2020. PFE's most recent quarterly dividend payment was made to shareholders of record on Friday, March 5. Pfizer Declares First-Quarter 2021 Dividend, Therapeutic Modalities and Technology Platforms, Small Molecule Product & Process Development, Maintaining Emotional Well-Being During COVID-19, Coronavirus disease (COVID-19) Scientific Resources, Meet our new Chief Patient Officer, Dr. Dara Richardson-Heron, Creating Cures Through Facility Investments, https://www.businesswire.com/news/home/20201211005015/en/. Chuck Triano To help you reduce price risk in your dividend portfolio, here are the dividend stocks that … A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results,” as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com. Pfizer pharma is an mnc pharma company. /*-->*/, Board of Directors approves quarterly cash dividend of $0.39 per share. The transaction to combine Upjohn with Mylan to form Viatris Inc. closed on November 16, 2020. PFE estimated in Dec. 2020 that vaccine sales would come in at 6 billion in 2021. Reply Replies (3) These symbols will be available throughout the site during your session. Try Premium. Pfizer has announced special dividend of 320 per share. Our premium tools have predicted Pfizer Inc. with 99% accuracy. You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. Record Date. 4.7%. The information contained in this release is as of December 11, 2020. Copyright © 2002-2021 Pfizer Inc. All rights reserved. “Our commitment to returning capital to shareholders is strong and the dividend increase reflects our continued confidence in the business and in our scientific pipeline,” stated Dr. Albert Bourla, Pfizer Chairman and CEO. (212) 733-7410 Type. Pfizer's next dividend payment date has not been announced yet. The company has grown its dividend for the last 1 consecutive years and is increasing its dividend by an average of … “It also reinforces that our focus on creating meaningful value for patients benefits all our stakeholders.”, Pfizer Inc.: Breakthroughs that change patients’ lives. NEW YORK--(BUSINESS WIRE)-- Ex-dividend date is at 04/30/2021 one working day after annual general meeting. The current TTM dividend payout for Pfizer (PFE) as of March 10, 2021 is $1.56 . The information contained in this release is as of December 11, 2020. It is expected that Viatris will begin paying a quarterly dividend in the second quarter of 2021, at which time Pfizer’s quarterly dividend will be reduced such that the combined dividend dollar amount received by Pfizer shareholders, based upon the combination of continued Pfizer ownership and approximately 0.124079 shares of Viatris which were granted for each Pfizer share in the spin-off, will equate to Pfizer’s dividend amount in effect immediately prior to the initiation of the Viatris dividend. Pfizer to exceed 2021 vaccine production target by as much as 20%, CEO says Yahoo 03/11 12:00 ET 100% reopening is ‘a little easier to enforce’ than 50% or 78%: governor #block-survival { display: none; } @media only screen and (min-width: 75rem) { .multiple-lines-intraday-chart .content-3-up__item.content-3-up__item { flex-basis: 31%; }} We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Pfizer on Friday announced a 2.6% dividend increase for the first quarter of 2021, raising its quarterly payout from 38 cents per share to 39 cents. The dividend yield is calculated by dividing the annual dividend payment by the prevailing share price. The current BASF dividend yield based on last share price is 4.69 %. 01/28/2021. Pfizer increased the dividend over the fourth-quarter 2020 dividend by approximately 3 percent to 39 cents from 38 cents per share. The board of directors of Pfizer Inc. (NYSE:PFE) declared a 39-cent first-quarter 2021 dividend on the company’s common stock, payable March 5, 2021, to holders of the Common Stock of record at the close of business on January 29, 2021. Pfizer Inc. (NYSE:PFE) declared a quarterly dividend on Friday, December 11th, RTT News reports. The board of directors of Pfizer Inc. (NYSE:PFE) declared a 39-cent first-quarter 2021 dividend on the company’s common stock, payable March 5, 2021, to holders of the Common Stock of record at the close of business on January 29, 2021. Create your Watchlist to save your favorite quotes on Nasdaq.com. Pfizer pays an annual dividend of $1.56 per share, with a dividend yield of 4.47%. This release contains forward-looking information about the Company’s quarterly dividend in 2021 that involves substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Amy Rose 03/05/2021. Amy.Rose@pfizer.com Board of Directors approves quarterly cash dividend of $0.39 per share. Due to the timing of the dividend initiation, the company expects to make three payments in 2021, totaling $400 million. Dividend & Split History. Date Amount Type Yield Change Decl. [CDATA[/* >